• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INSULET CORPORATION OMNIPOD DASH INSULIN MANAGEMENT SYSTEM; PUMP, INFUSION, INSULIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INSULET CORPORATION OMNIPOD DASH INSULIN MANAGEMENT SYSTEM; PUMP, INFUSION, INSULIN Back to Search Results
Model Number 18320
Device Problems Loss of or Failure to Bond (1068); Unintended Movement (3026)
Patient Problems Hyperglycemia (1905); Nausea (1970)
Event Date 04/15/2023
Event Type  Injury  
Event Description
It was reported that the patient visited the emergency room (er) due to high blood glucose (bg) levels >500 mg/dl and nausea, while wearing the pod o the hip/buttocks area between 5 and 24 hours.The pod had fallen off, dislodging the cannula from the infusion site.At the hospital, the patient was administered insulin injections, placed on an intravenous (iv) of fluids for hydration and given some pills to control the nausea.The pod was discarded.
 
Manufacturer Narrative
According to the complainant the device will not be available for investigation because it was discarded.We are unable to determine if any product condition could have contributed to the reported er visit and hyperglycemia.It was reported that the cannula had dislodged from the infusion site.This condition could interrupt insulin delivery and contribute to hyperglycemia.Lot release records were reviewed and the product lot met all acceptance criteria.Specifically, a pod is paired to a pdm and put through simulated use testing including communicating with the pdm, deployment, delivering fluid, occlusion detection, and freedom from hazard alarms.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OMNIPOD DASH INSULIN MANAGEMENT SYSTEM
Type of Device
PUMP, INFUSION, INSULIN
Manufacturer (Section D)
INSULET CORPORATION
100 nagog park
acton MA 01720
Manufacturer (Section G)
INSULET CORPORATION
100 nagog park
acton MA 01720
Manufacturer Contact
thom mcnamara
100 nagog park
acton, MA 01720
9786007000
MDR Report Key16785698
MDR Text Key313730215
Report Number3004464228-2023-10257
Device Sequence Number1
Product Code LZG
UDI-Device Identifier20385082000020
UDI-Public(01)20385082000020(11)220511(17)231111(10)PD1K05112231
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K211575
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 04/20/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/21/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date11/11/2023
Device Model Number18320
Device Catalogue NumberBLE-I1-529
Device Lot NumberPD1K05112231
Was Device Available for Evaluation? No
Date Manufacturer Received04/20/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/11/2022
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age27 YR
Patient SexMale
-
-